Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Archivos Españoles de Urología (Ed. impresa)
versión impresa ISSN 0004-0614
Resumen
GARCIA RODRIGUEZ, Jorge et al. Intravesical therapy: influence on superficial bladder cancer progresion. Arch. Esp. Urol. [online]. 2007, vol.60, n.1, pp.31-35. ISSN 0004-0614.
Objectives: To review the influence of various intravesical treatments on superficial bladder cancer progression. Methods: We retrospectively reviewed 473 superficial bladder neoplasias. Based on diagnosis and transurethral resection of bladder tumor (TUR BT), and depending on pathology, we proposed different treatment and follow-up schemes, with BCG in 139 cases and intravesical chemotherapy, mainly Mytomicin C, in 80. Results: Overall, the use or not of bladder instillations did not show statistically significant differences in time to progression. The use of intravesical therapy and maintenance therapy was an independent risk factor for disease-free time to progression when compared with induction. Conclusions: The use of maintenance intravesical therapy with BCG resulted in a delayed progression of superficial bladder cancer, so that it seems the most effective treatment, mainly in moderate-high risk tumors.
Palabras clave : Superficial bladder cancer; Progression; Intravesical treatment.